A detailed history of Bank Of Montreal transactions in Biogen Inc. stock. As of the latest transaction made, Bank Of Montreal holds 219,911 shares of BIIB stock, worth $34.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
219,911
Previous 234,331 6.15%
Holding current value
$34.7 Million
Previous $54.3 Million 21.53%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$189.07 - $236.8 $2.73 Million - $3.41 Million
-14,420 Reduced 6.15%
219,911 $42.6 Million
Q2 2024

Aug 14, 2024

SELL
$190.52 - $236.72 $473,251 - $588,012
-2,484 Reduced 1.05%
234,331 $54.3 Million
Q1 2024

May 13, 2024

SELL
$212.02 - $267.71 $11.8 Million - $14.9 Million
-55,585 Reduced 19.01%
236,815 $51.1 Million
Q4 2023

Feb 08, 2024

BUY
$222.59 - $267.94 $19 Million - $22.9 Million
85,557 Added 41.36%
292,400 $75.7 Million
Q3 2023

Nov 01, 2023

SELL
$253.3 - $285.89 $2.6 Million - $2.94 Million
-10,272 Reduced 4.73%
206,843 $53.2 Million
Q2 2023

Aug 02, 2023

SELL
$275.25 - $318.06 $29.4 Million - $33.9 Million
-106,692 Reduced 32.95%
217,115 $61.8 Million
Q1 2023

Jun 13, 2024

SELL
$256.56 - $292.34 $9.03 Million - $10.3 Million
-35,191 Reduced 14.86%
201,624 $56.1 Million
Q4 2022

Feb 01, 2023

BUY
$252.44 - $306.72 $11.2 Million - $13.7 Million
44,533 Added 15.95%
323,807 $89.7 Million
Q3 2022

Nov 10, 2022

BUY
$194.69 - $268.46 $9.86 Million - $13.6 Million
50,627 Added 22.14%
279,274 $75.7 Million
Q2 2022

Aug 11, 2022

BUY
$187.54 - $223.02 $11.7 Million - $13.9 Million
62,544 Added 37.65%
228,647 $56 Million
Q1 2022

May 12, 2022

SELL
$193.77 - $244.14 $21.8 Million - $27.5 Million
-112,577 Reduced 40.4%
166,103 $40.7 Million
Q4 2021

Feb 11, 2022

SELL
$223.92 - $287.77 $2.02 Million - $2.6 Million
-9,019 Reduced 3.13%
278,680 $68.3 Million
Q3 2021

Nov 12, 2021

BUY
$282.99 - $369.05 $26.9 Million - $35.1 Million
95,105 Added 49.38%
287,699 $91.7 Million
Q2 2021

Aug 12, 2021

BUY
$259.0 - $414.71 $49.9 Million - $79.9 Million
192,594 New
192,594 $79 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.